Zevra Therapeutics, Inc. ZVRA Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $83.23M+179% | -$105.51M-129% | -$46.05M— | —— | ||
| $4.05M-36.5% | $6.39M+535% | $1.01M+6.6% | $944K+267% | ||
| $12.63M-15.2% | $14.91M+150% | $5.95M+38.7% | $4.29M+76.3% | ||
| —— | -$69.67M-108% | -$33.54M-79.2% | -$18.72M— | ||
| $866K— | $0-100% | $296K+218% | $93K-8.8% | ||
| —— | -$22.16M— | —— | -$36.99M-138% | ||
| $0— | —— | $17.74M— | $0— | ||
| $12.06M-85.3% | $82.11M+188% | $28.46M— | —— | ||
| $28.62M+409% | -$9.26M+58.7% | -$22.42M+52.2% | -$46.88M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Zevra Therapeutics, Inc. generate?
- Zevra Therapeutics, Inc. (ZVRA) generated -$21.9M in operating cash flow over the trailing twelve months.
- What is Zevra Therapeutics, Inc.'s free cash flow?
- After $802.0K of capital expenditures, Zevra Therapeutics, Inc.'s free cash flow was -$22.3M over the trailing twelve months, up 68.0% year over year.
- Where does Zevra Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Zevra Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
